SUVmax | ||||
Patient | Lesion | Baseline | 24 h | Change (%) |
1 | Primary | 3.60 | 2.07 | −42.6 |
Lymph node A | 4.02 | 1.42 | −64.7 | |
Lymph node B | 3.89 | 3.36 | −13.7 | |
Lymph node C | 3.79 | 2.54 | −33.1 | |
Lymph node D | 3.32 | 2.72 | −18.1 | |
Lymph node E | 2.34 | 1.53 | −34.4 | |
2 | Primary | 8.42 | 7.22 | −14.3 |
Lymph node A | 5.74 | 4.60 | −19.9 | |
Lymph node B | 5.18 | 5.04 | −2.80 | |
3 | Primary | 3.26 | 2.07 | −36.4 |
Lymph node A | 2.36 | 1.77 | −25.1 | |
Lymph node B | 1.64 | 0.75 | −54.3 | |
Lymph node C | 1.49 | 0.85 | −42.8 | |
4 | Tumor A | 2.08 | 1.85 | −11.4 |
Tumor B | 4.00 | 3.43 | −14.3 | |
Lymph node A | 6.13 | 6.83 | 11.5 | |
Lymph node B | 4.90 | 4.07 | −17.0 | |
Lymph node C | 3.48 | 1.93 | −44.6 |